Adhd - Articles - Page 6 | CARLAT PUBLISHING

Fact Sheet

Guanfacine (Intuniv, Tenex) for Children and Adolescents

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Guanfacine’s advantages over stimulants include no worsening of tic disorders, lack of misuse potential, and no insomnia.

Fact Sheet

Dextroamphetamine Transdermal (Xelstrym) for Children and Adolescents

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

A patch option in the amphetamine class of stimulants for kids who cannot use the wide array of oral stimulants available today.

Fact Sheet

Atomoxetine (Strattera) for Children and Adolescents

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Unlike stimulants, atomoxetine has no abuse potential, causes less insomnia and anxiety, and is unlikely to worsen tics.

Fact Sheet

Amphetamine (Adzenys XR-ODT, Dyanavel XR, Evekeo) for Children and Adolescents

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Newer formulations of an old drug come with a high price tag. Stick to the usual amphetamine products like mixed amphetamine salts unless liquid or ODT dosing is absolutely necessary.

Algorithm

ADHD Treatment Algorithm for Children and Adolescents

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

ADHD treatment algorithm for children and adolescents

Clinical Update

Stimulant Dosing Limits

August 7, 2023

Chris Aiken, MD and Kelvin Quiñones-Laracuente, MD, PhD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Kelvin Quiñones-Laracuente, MD, PhD. Psychiatry resident, NYU Langone Medical Center.

Drs. Aiken and Quiñones-Laracuente have no financial relationships with companies related to this material.

Dosing is not a collaborative venture when it comes to controlled substances, and here we look for the safe upper limits of stimulant dosing.

CARLAT WEBINAR

Aggression in Psychiatric Practice

May 24, 2023

Joshua Feder, MD

0.50 CME Credits. Learn to mitigate aggression in psychiatric practice in this webinar. You will gain expertise in understanding, treating, and preventing challenging behaviors in children and adults.

Psychopharm Commandments 8A: Polypharmacy Makeover

May 1, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

How to reduce unnecessary polypharmacy, and when it makes sense to keep it going.

Research Update

Stimulant Treatment Effect on Anxiety in ADHD

April 1, 2023

Gaurav Mishra, MD

Gaurav Mishra, MD. Dr. Mishra has no financial relationships with companies related to this material.

Are stimulant medication likely to exacerbate anxiety in ADHD kids? It’s reasonable concern, especially since mood symptoms can be worse with withdrawal and heart rate goes up in some kids on stimulants. This study gives nuanced insight into the degree to which stimulants impact anxiety in ADHD kids, for better and worse.

Research Update

Does Treatment of ADHD Help Caregiver Stress?

April 1, 2023

Muruga Loganathan, MD

Muruga Loganathan, MD. Dr. Loganathan has no financial relationships with companies related to this material.

Parents suffer significant stress, doing their best to support and care for their ADHD kids. Does that stress dissipate at all when the ADHD is alleviated? This controlled trial looked at stress levels of parents whose kids were taking delayed release/extended release methylphenidate versus those taking placebo.